QQQ   293.36 (-0.12%)
AAPL   147.96 (-0.24%)
MSFT   255.87 (+0.46%)
META   123.98 (+2.94%)
GOOGL   100.71 (-0.28%)
AMZN   94.45 (-1.10%)
TSLA   194.98 (+0.14%)
NVDA   169.27 (-1.21%)
NIO   13.18 (+9.02%)
BABA   90.60 (+5.42%)
AMD   75.79 (-2.18%)
T   19.03 (-0.83%)
MU   54.37 (-2.02%)
CGC   4.27 (+8.65%)
F   13.88 (-1.42%)
GE   86.94 (+1.97%)
DIS   99.57 (+0.99%)
AMC   8.40 (+2.82%)
PYPL   75.28 (-4.14%)
PFE   51.02 (-0.12%)
NFLX   321.42 (+1.41%)
QQQ   293.36 (-0.12%)
AAPL   147.96 (-0.24%)
MSFT   255.87 (+0.46%)
META   123.98 (+2.94%)
GOOGL   100.71 (-0.28%)
AMZN   94.45 (-1.10%)
TSLA   194.98 (+0.14%)
NVDA   169.27 (-1.21%)
NIO   13.18 (+9.02%)
BABA   90.60 (+5.42%)
AMD   75.79 (-2.18%)
T   19.03 (-0.83%)
MU   54.37 (-2.02%)
CGC   4.27 (+8.65%)
F   13.88 (-1.42%)
GE   86.94 (+1.97%)
DIS   99.57 (+0.99%)
AMC   8.40 (+2.82%)
PYPL   75.28 (-4.14%)
PFE   51.02 (-0.12%)
NFLX   321.42 (+1.41%)
QQQ   293.36 (-0.12%)
AAPL   147.96 (-0.24%)
MSFT   255.87 (+0.46%)
META   123.98 (+2.94%)
GOOGL   100.71 (-0.28%)
AMZN   94.45 (-1.10%)
TSLA   194.98 (+0.14%)
NVDA   169.27 (-1.21%)
NIO   13.18 (+9.02%)
BABA   90.60 (+5.42%)
AMD   75.79 (-2.18%)
T   19.03 (-0.83%)
MU   54.37 (-2.02%)
CGC   4.27 (+8.65%)
F   13.88 (-1.42%)
GE   86.94 (+1.97%)
DIS   99.57 (+0.99%)
AMC   8.40 (+2.82%)
PYPL   75.28 (-4.14%)
PFE   51.02 (-0.12%)
NFLX   321.42 (+1.41%)
QQQ   293.36 (-0.12%)
AAPL   147.96 (-0.24%)
MSFT   255.87 (+0.46%)
META   123.98 (+2.94%)
GOOGL   100.71 (-0.28%)
AMZN   94.45 (-1.10%)
TSLA   194.98 (+0.14%)
NVDA   169.27 (-1.21%)
NIO   13.18 (+9.02%)
BABA   90.60 (+5.42%)
AMD   75.79 (-2.18%)
T   19.03 (-0.83%)
MU   54.37 (-2.02%)
CGC   4.27 (+8.65%)
F   13.88 (-1.42%)
GE   86.94 (+1.97%)
DIS   99.57 (+0.99%)
AMC   8.40 (+2.82%)
PYPL   75.28 (-4.14%)
PFE   51.02 (-0.12%)
NFLX   321.42 (+1.41%)
NASDAQ:CUTR

Cutera - CUTR Stock Forecast, Price & News

$51.63
+1.66 (+3.32%)
(As of 12/2/2022 03:10 PM ET)
Add
Compare
Today's Range
$49.05
▼
$51.63
50-Day Range
$39.63
▼
$49.97
52-Week Range
$31.62
▼
$74.38
Volume
11,658 shs
Average Volume
338,217 shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$70.75

Cutera MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
38.8% Upside
$70.75 Price Target
Short Interest
Bearish
18.61% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.53mentions of Cutera in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.39) to ($0.66) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Computer And Technology Sector

524th out of 640 stocks

Electromedical Equipment Industry

16th out of 22 stocks

See Top Rated MarketRank™ Stocks Here
CUTR stock logo

About Cutera (NASDAQ:CUTR) Stock

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Stock News Headlines

December 2, 2022 | seekingalpha.com
Cutera: AviClear Key Differentiator, Reaffirm Buy
November 21, 2022 | finance.yahoo.com
Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference
November 10, 2022 | finance.yahoo.com
Cutera, Inc. to Participate in a Fireside Chat at the Stifel Healthcare 2022 Conference
November 10, 2022 | finance.yahoo.com
Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference
November 8, 2022 | finance.yahoo.com
Cutera Third Quarter 2022 Earnings: EPS Misses Expectations
November 7, 2022 | finance.yahoo.com
AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch
November 5, 2022 | seekingalpha.com
Cutera surges 12% as FY22 revenue outlook maintained despite forex impact
November 4, 2022 | finance.yahoo.com
Cutera Announces Third Quarter 2022 Financial Results
November 4, 2022 | finance.yahoo.com
Cutera (CUTR) Reports Q3 Loss, Tops Revenue Estimates
October 25, 2022 | finance.yahoo.com
Cutera’s AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology Conference
October 17, 2022 | nasdaq.com
Zacks Industry Outlook Highlights IPG Photonics and Cutera - Nasdaq
October 13, 2022 | nasdaq.com
Implied SPTM Analyst Target Price: $58 - Nasdaq
October 12, 2022 | benzinga.com
Medical Laser Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM - Benzinga
October 3, 2022 | businesswire.com
Global Hair Removal Market to Reach $1.2 Billion by 2027 at a CAGR of 10.44% - ResearchAndMarkets.com - Business Wire
September 30, 2022 | businesswire.com
Global Laser Hair Removal Market Report 2022: Conventional and Technological Advancement in Aesthetic Lasers Treatment Drives Growth - ResearchAndMarkets.com - Business Wire
September 30, 2022 | globenewswire.com
$11+ Billion Dermatology Devices Market Size to Grow at 11.2% CAGR, Globally, by 2028 - Growing Prevalence of Skin Cancers and Skin Disorders - GlobeNewswire
September 26, 2022 | businesswire.com
Global Acne Treatment Market Report to 2027 - Featuring Galderma, Lumenis, Cutera and Alma Lasers Among Others - ResearchAndMarkets.com - Business Wire
September 25, 2022 | finance.yahoo.com
Cutera, Inc. (CUTR)
September 12, 2022 | businesswire.com
Global Breast Augmentation Market Research Report to 2027 - Featuring Allergan, Cutera, Hayden Medical and Medtronic Among Others - ResearchAndMarkets.com - Business Wire
September 8, 2022 | seekingalpha.com
Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS
September 8, 2022 | finance.yahoo.com
Cutera Announces Over 1,000 AviClear™ Acne Treatments Performed
September 8, 2022 | businesswire.com
Cutera Announces Over 1000 AviClear™ Acne Treatments Performed - Business Wire
September 7, 2022 | finance.yahoo.com
Conformal Medical Announces Leadership Transition - Yahoo Finance
August 31, 2022 | fool.com
Cutera (NASDAQ: CUTR)
August 22, 2022 | businesswire.com
$4.3 Billion Non-invasive Fat Reduction Markets: Cryolipolysis, Ultrasound, Low Level Lasers - Global Forecast to 2030 - ResearchAndMarkets.com - Business Wire
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Company Calendar

Last Earnings
11/03/2021
Today
12/02/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/28/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
NASDAQ:CUTR
CUSIP
N/A
CIK
1162461
Web
www.cutera.com
Phone
(415) 657-5500
Fax
415-330-2444
Employees
461
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$70.75
High Stock Price Forecast
$80.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+37.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($4.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.06 million
Net Margins
-31.31%
Pretax Margin
-30.77%
Return on Equity
-225.70%
Return on Assets
-22.44%

Debt

Debt-to-Equity Ratio
19.38
Current Ratio
3.73
Quick Ratio
3.16

Sales & Book Value

Annual Sales
$231.27 million
Price / Sales
4.38
Cash Flow
$0.36 per share
Price / Cash Flow
143.04
Book Value
$0.79 per share
Price / Book
65.35

Miscellaneous

Outstanding Shares
19,610,000
Free Float
19,203,000
Market Cap
$1.01 billion
Optionable
Optionable
Beta
1.69

Social Links


Key Executives

  • Mr. J. Daniel PlantsMr. J. Daniel Plants (Age 55)
    Exec. Chairman
    Comp: $396.25k
  • Mr. David H. MowryMr. David H. Mowry (Age 60)
    CEO & Director
    Comp: $1.47M
  • Mr. Rohan R. SethMr. Rohan R. Seth (Age 44)
    Chief Financial Officer
    Comp: $628.55k
  • Dr. Michael A. Karavitis Ph.D. (Age 52)
    Exec. VP & Chief Technology Officer
    Comp: $811.89k
  • Mr. Charles G. Thier (Age 59)
    Chief Information Officer
    Comp: $620.84k
  • Anne Werdan
    Director of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CUTR Stock - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CUTR shares.
View CUTR analyst ratings or view top-rated stocks.

What is Cutera's stock price forecast for 2023?

3 brokerages have issued 1 year price objectives for Cutera's shares. Their CUTR share price forecasts range from $55.00 to $80.00. On average, they predict the company's share price to reach $70.75 in the next twelve months. This suggests a possible upside of 38.5% from the stock's current price.
View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2022?

Cutera's stock was trading at $41.32 at the beginning of 2022. Since then, CUTR stock has increased by 23.6% and is now trading at $51.09.
View the best growth stocks for 2022 here.

Are investors shorting Cutera?

Cutera saw a decrease in short interest in November. As of November 15th, there was short interest totaling 3,650,000 shares, a decrease of 18.2% from the October 31st total of 4,460,000 shares. Based on an average daily volume of 285,800 shares, the short-interest ratio is presently 12.8 days.
View Cutera's Short Interest.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our CUTR earnings forecast.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its earnings results on Wednesday, November, 3rd. The medical device company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.11. The medical device company earned $57.38 million during the quarter, compared to analyst estimates of $50.90 million. Cutera had a negative net margin of 31.31% and a negative trailing twelve-month return on equity of 225.70%. During the same period last year, the company posted ($0.13) earnings per share.

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $255.00 million-$260.00 million, compared to the consensus revenue estimate of $258.06 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.68%), Vanguard Group Inc. (6.18%), Gamco Investors INC. ET AL (5.44%), First Light Asset Management LLC (3.89%), State Street Corp (3.49%) and Eagle Asset Management Inc. (3.21%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $51.09.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $1.00 billion and generates $231.27 million in revenue each year. The medical device company earns $2.06 million in net income (profit) each year or ($4.21) on an earnings per share basis.

How many employees does Cutera have?

The company employs 461 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 12/2/2022 by MarketBeat.com Staff